All Stories

  1. Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study
  2. Manejo y factores de riesgo de mortalidad del estatus epiléptico: estudio retrospectivo
  3. Concordance between fMRI and Wada test for memory lateralization in temporal lobe epilepsy: A meta-analysis and systematic review
  4. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy
  5. Comparing the Wada Test and Functional MRI for the Presurgical Evaluation of Memory in Temporal Lobe Epilepsy
  6. Evidence for Cholinergic Dysfunction in Autosomal Dominant Kufs Disease
  7. Comparing the Intracarotid Amobarbital Test and Functional MRI for the Presurgical Evaluation of Language in Epilepsy
  8. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure
  9. Outcome of temporal lobe epilepsy surgery evaluated with bitemporal intracranial electrode recordings
  10. Marijuana use in adults admitted to a Canadian epilepsy monitoring unit
  11. Palatal and Oromandibular Tremor Secondary to Degenerative Olivary Hypertrophy After Ependymoma Surgery
  12. Coprolalia as a manifestation of epileptic seizures
  13. Marijuana use in intractable epilepsy
  14. Concordance rate between Wada and fMRI tests for visual memory assessment of patients with medically intractable temporal lobe epilepsy
  15. fMRI for language: how can it replace the Wada test?
  16. Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence
  17. Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results
  18. Estudio postautorización de la eslicarbazepina en el tratamiento de epilepsias farmacorresistentes: resultados preliminares
  19. Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine
  20. Safety study of long-term video-electroencephalogram monitoring
  21. Estudio de seguridad en la monitorización por vídeo-electroencefalograma prolongado
  22. Decreased Levels of Angiogenic Growth Factors in Intracranial Atherosclerotic Disease despite Severity-Related Increase in Endothelial Progenitor Cell Counts
  23. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease
  24. C-Reactive Protein Gene C1444T Polymorphism and Risk of Recurrent Ischemic Events in Patients with Symptomatic Intracranial Atherostenoses